07:00 , May 30, 2011 |  BC Week In Review  |  Company News

ACS Biomarker management update

ACS Biomarker B.V., Maastricht, the Netherlands   Business: Diagnostic, Cardiovascular   Hired: Heico Breek as CEO, formerly CEO of Cavadis B.V.   ...
07:00 , May 30, 2011 |  BC Week In Review  |  Financial News

ACS Biomarker completes venture financing

ACS Biomarker B.V., Maastricht, the Netherlands   Business: Diagnostic, Cardiovascular   Date completed: 5/20/11   Type: Venture financing   Raised: Not disclosed   Investors: Life Sciences Fund Amsterdam; Limburg Ventures   ...
08:00 , Feb 11, 2008 |  BC Week In Review  |  Company News

ACS Biomarker B.V. i.o., BG Medicine deal

BG Medicine received exclusive, worldwide rights to develop and commercialize a clinical diagnostic test for acute atherothrombosis based on an undisclosed biomarker from ACS Biomarker. ACS Biomarker is eligible for milestones, royalties and sublicensing income....
07:00 , May 28, 2007 |  BC Week In Review  |  Company News

ACS Biomarker B.V. i.o., BG Medicine deal

BG Medicine received exclusive, worldwide rights to develop and commercialize molecular diagnostics for congestive heart failure (CHF) based on ACS Biomarker's galectin-3 and thromboplastin-2 blood plasma biomarkers. BG Medicine also has certain preferential rights...